This webinar outlines WuXi AppTec HitS’s 3rd. generation of DEL kits.
The newly upgraded DEL kits feature an interactive platform and
provide access to larger and more diverse compound libraries.
DELopen is a freely accessible collection of DELs for academic drug-discovery.
DELight allows pharmaceutical companies to conduct a DEL screen in their own lab,
without needing to reveal the identity of their target.
Experiences shared by DEL kits collaborators
New features of 3rd Generation DEL kits
Key Information
How to Apply for DEL Kits
One-stop Target-to-Hit services
WuXi AppTec’s HitS unit provides one-stop Target-to-Hit services to enable companies in pharmaceuticals, biotechnology and academia to pursue their goals in drug discovery. As an innovation-driven and customer-focused unit, WuXi AppTec HitS provides solutions to help partners improve the productivity of hit discovery activities.
Protein Screening Biophysics Biochemistry Structural Biology
With industry-leading capabilities such as protein science, biophysics, DNA-encoded library technology, and structural biology, WuXi AppTec’s HitS is committed to drive toward the realization of the vision that every drug can be made and every disease can be treated.
Ready to start your project